04.FDA Nonclinical Tox Expectations_Tacey.pdf
03.The Role and Impact of Pathology_Peter.pdf
05.Peer Review in Histopathology Evaluations_Peter.pdf
02.Translational Medicine_Ada.pdf
01.FDA Overview Presentation_Tacey.pdf
06.Navigating DART Challenges_Tacey.pdf
09.CFDA perspectives_Ada.pdf
08.Methods for expediting innovative_Ada.pdf
07.Adversity in Toxicology Studies_Peter.pdf
